VARENICLINE TARTRATE | A216723 | ZYDUS WORLDWIDE DMCC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Par Pharmaceutical, Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al 2 patentsANDA 216723, 2011785varenicline tartrate | D. Del. | 2023-08-08 | Terminated 2024-12-20 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.4185
per ea
Lowest NADAC/Unit
$0.3191
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 70710161406VARENICLINE 1 MG TABLET | $0.4185 | EA | Generic | — | 2026-06-17 |
| 70710161306VARENICLINE 0.5 MG TABLET | $0.3191 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.